Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „exposures“
Suchtreffer
Begriffe & Kennungen
Abiraterone Mylan · 4.5 · Potential to affect exposures to other medicinal products Abiraterone is an inhibitor of the hepatic drug-meta
Eintrag öffnenAdcetris · 4.5 · The pharmacokinetics of ADC and MMAE have not been characterized in the setting of BrECADD. Exposures of brent
Eintrag öffnenAmyvid · 4.8 · 7 b Post-marketing adverse reaction. Frequency assessment based on post-marketing exposures. Symptoms may incl
Eintrag öffnenBerufsbedingte Belastung
Eintrag öffnenCresemba · 4.5 · Potential for isavuconazole to affect exposures of other medicines
Eintrag öffnenCresemba · 4.5 · Potential for isavuconazole to affect exposures of other medicines
Eintrag öffnenEnzalutamide Viatris · 4.5 · Effect of food on enzalutamide exposures
Eintrag öffnenEnzalutamide Viatris · 4.5 · Potential for enzalutamide to affect exposures to other medicinal products
Eintrag öffnenEnzalutamide Viatris · 4.5 · Potential for other medicinal products to affect enzalutamide exposures
Eintrag öffnenEpysqli · 4.5 · Concomitant use of eculizumab with neonatal Fc receptor (FcRn) blockers may lower systemic exposures and reduc
Eintrag öffnenErleada · 4.5 · Potential for apalutamide to affect exposures to other medicinal products
Eintrag öffnenErleada · 4.5 · Potential for apalutamide to affect exposures to other medicinal products
Eintrag öffnenErleada · 4.5 · Potential for other medicinal products to affect apalutamide exposures
Eintrag öffnenErleada · 4.5 · Potential for other medicinal products to affect apalutamide exposures
Eintrag öffnenExposition gegenüber Inhalationsstoffen
Eintrag öffnenGazyvaro · 4.8 · **Based on clinical trial exposures in FL and CLL
Eintrag öffnenGenvoya · 4.5 · Co-administration with Genvoya may lead to decreased elvitegravir and/or cobicistat exposures and loss of ther
Eintrag öffnenIbrance · 4.5 · Data from a DDI study in healthy male subjects indicated that palbociclib exposures were comparable when a sin
Eintrag öffnenIbrance · 4.5 · Data from a DDI study in healthy male subjects indicated that palbociclib exposures were comparable when a sin
Eintrag öffnenKaftrio · 4.5 · ELX and IVA are inhibitors of BCRP. Co-administration of IVA/TEZ/ELX, and IVA may increase exposures of medici
Eintrag öffnen